Nanostructured Lipid Carriers of Donepezil Hydrochloride for the Treatment of Alzheimer's Disease

CONCLUSION: The DNZ-loaded NLCs, when administered via nasal route, showed markedly improved drug availability in the brain, suggesting an efficient drug delivery strategy to treat Alzheimer's disease.PMID:38445703 | DOI:10.2174/0115672050288659240229080535

Source: Current Alzheimer Research - March 6, 2024 Category: Neurology Authors: Avinash Tekade Ram Susar Gajanan Kulkarni Samiksha Surwade Anil Gaikwad Source Type: research